P700: TREATMENT-FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5-YEAR RESULTS OF DASFREE

oleh: N. P. Shah, V. García-Gutiérrez, A. Jiménez-Velasco, S. Saussele, D. Rea, F.-X. Mahon, M. Y. Levy, M. T. Gómez-Casares, M. J. Mauro, O. Sy, P. Martin-Regueira, J. H. Lipton

Format: Article
Diterbitkan: Wiley 2022-06-01

Deskripsi

No description available for this item.